NCT04230070View on ClinicalTrials.gov

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 24, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

November 17, 2020

Conditions
Bioequivalence
Interventions
DRUG

Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug

Bioequivalence

DRUG

Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Reference Product

Bioequivalence

Trial Locations (1)

7510491

Innolab, Santiago

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT04230070 - Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product | Biotech Hunter | Biotech Hunter